India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities. IMAGE: A healthcare worker......
The World Health Organisation (WHO) on Friday issued emergency use listing for anti-COVID vaccine Covovax produced by Serum Institute of India under licence from Novavax, expanding the basket of......
India currently does not have any XBB 1.5 variant-based vaccines available. IMAGE: A healthcare worker prepares a dose of a COVID-19 vaccine. Photograph: ANI Photo New-generation Covid......
With the government approving two COVID-19 vaccines for emergency use, Serum Institute on Sunday said it is ready to roll out Covishield vaccine in India in the coming weeks, while Bharat Biotech......
This will also help test the effectiveness of preventing the entry of Nipah in target cells. IMAGE: Field lab assistants anaesthetise a bat at a field laboratory as they research the Nipah virus.......
The Central Drugs Standard Control Organisation said while the rights, safety, and well-being of trial subjects were of paramount importance, protocol amendment, deviation or modification might be......